Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemostatic changes in patients with brain tumors

L Thoron1, E Arbit

  • 1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

Journal of Neuro-Oncology
|January 1, 1994
PubMed
Summary

Cancer patients exhibit hemostatic abnormalities, with brain tumor patients experiencing higher thromboembolism rates. This review explores differences in blood abnormalities and clinical signs between cancer and brain tumor patients to understand varying causes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

More on: the role of thrombin in gliomas.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects.

Diabetes, obesity & metabolism·2010
Same author

Pharmacokinetics and pharmacodynamic effects of oral GLP-1 and PYY3-36: a proof-of-concept study in healthy subjects.

Clinical pharmacology and therapeutics·2009
Same author

More on: The role of thrombin in gliomas.

Journal of thrombosis and haemostasis : JTH·2006
Same author

A novel per-oral insulin formulation: proof of concept study in non-diabetic subjects.

Diabetic medicine : a journal of the British Diabetic Association·2004
Same author

Treatment of refractory recurrent malignant glioma with adoptive cellular immunotherapy: a case report.

Critical reviews in oncology/hematology·2001

Area of Science:

  • Oncology
  • Hematology
  • Neuroscience

Background:

  • Abnormal hemostasis is a known characteristic of cancer.
  • Hemostatic abnormalities are frequently observed in patients with systemic malignant diseases and brain tumors.
  • Thromboembolism incidence is notably higher in brain tumor patients compared to those with systemic cancers.

Purpose of the Study:

  • To investigate potential differences in hemostatic abnormalities between patients with brain tumors and systemic cancers.
  • To explore if these differences suggest distinct underlying pathogeneses.
  • To review blood abnormalities and clinical manifestations of abnormal hemostasis in these patient groups, considering central nervous system-specific hemostatic features.

Main Methods:

  • Literature review of studies on hemostasis in cancer patients.

Related Experiment Videos

  • Comparative analysis of hemostatic abnormalities in systemic cancer versus brain tumor cohorts.
  • Examination of clinical manifestations associated with abnormal hemostasis.
  • Consideration of normal hemostasis, particularly aspects relevant to the central nervous system.

    • Main Results:

    • Systemic cancer and brain tumors are associated with hemostatic abnormalities.
    • Brain tumors present a higher incidence of thromboembolism than systemic cancers.
    • Differences in hemostatic abnormalities may indicate divergent pathological mechanisms.

    Conclusions:

    • Hemostatic abnormalities are a common feature in cancer, but the specific profile may differ between brain tumors and systemic malignancies.
    • The higher thromboembolism rate in brain tumors suggests unique hemostatic dysregulation.
    • Further research into CNS-specific hemostasis is warranted to elucidate these differences.